Epicardial Versus Transvenous Implantable Cardioverter Defibrillators in Children
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 131
- 主要终点
- Number of patients with implantable cardioverter defibrillator system dysfunction (lead dysfunction requiring reintervention)
研究概览
简要总结
This observational study included all patients <18-year-old implanted with an Implantable cardioverter defibrillator (ICD) at Necker Hospital, Paris, France, from January 2003 to January 2021. Outcomes (ICD-related complications and reinterventions) were compared between epicardial and transvenous ICDs using Cox proportional hazard models.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 0 Years 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ICD implantation
- •Age < 18 years
排除标准
- •Absence of patient's consent
结局指标
主要结局
Number of patients with implantable cardioverter defibrillator system dysfunction (lead dysfunction requiring reintervention)
时间窗: up to 15 years
Number of patients in each group (epicardial and transvenous implantable cardioverter defibrillator) with an implantable cardioverter defibrillator dysfunction (dysfunction of at least one lead requiring reintervention) at the end of the follow-up
次要结局
未报告次要终点
